Clinical efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: five-year real-world results

BACKGROUND/AIM: To report 5-year real-world efficacy and safety data following the treatment of chronic diabetic macular oedema (DMO) with the intravitreal 0.19 mg fluocinolone acetonide implant(ILUVIEN). METHODS: Retrospective cohort study of 31 eyes treated with ILUVIEN for chronic DMO at a tertia...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobler, Emilie, Mohammed, Bashar Raouf, Chavan, Randhir, Lip, Peck Lin, Mitra, Arijit, Mushtaq, Bushra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745701/
https://www.ncbi.nlm.nih.gov/pubmed/36513858
http://dx.doi.org/10.1038/s41433-022-02338-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745701/
https://www.ncbi.nlm.nih.gov/pubmed/36513858
http://dx.doi.org/10.1038/s41433-022-02338-2

Ejemplares similares